The Pharmacist's Opportunity to Improve Disease–State Management in Cystic Fibrosis
0290-0000-18-095-L01-P
1.50
Optimized Care of Patients With COPD: Pharmacotherapy and Appropriate Use of Inhalers
0290-0000-18-051-H01-P
The faculty panel of this PTCE program will discuss pharmacologic agents in COPD management and other important topics pertaining to COPD.
1.50
Identifying Health–System Pharmacist's Role in Improving Pulmonary Arterial Hypertension and Transitions of Care
0290-0000-17-197-H01-P
This webinar will focus on pulmonary arterial hypertension as a disease state, and treatment guidelines and goals, which require a multidisciplinary approach.
1.00
Optimizing Patient Management in Lung Cancer
0290-0000-17-202-H01-P
With this PTCE program, the current available treatment approaches, including systemic and novel treatments, in lung cancer therapy will be analyzed.
1.00
Improving Treatment and Care in Patients with Lung Cancer: A Multidisciplinary Panel Discussion
0290-0000-17-203-H01-P
At the completion of this continuing education activity, pharmacists will be able to determine proper management of adverse events from lung cancer treatment.
1.50
The Role of the Convenient Care Provider and Pharmacist in Preventing and Treating Anaphylaxis
0290-0000-17-154-H01-P
This activity will differentiate between allergic and nonallergic anaphylaxis, and explore the available treatment options.
1.00
Improving Outcomes in Cystic Fibrosis: Role of the Specialty Pharmacist
0290-0000-17-189-H01-P
This podcast will review guidelines to screen and diagnose patients with cystic fibrosis and how to identify patients who qualify for CFTR modulator therapy.
1.00
An American Journal of Managed Care® Patient Perspective: Treating Idiopathic Pulmonary Fibrosis
0290-0000-17-162-H01-P
This panel will provide knowledge about IPF, the diagnosis process, the cost implications of treatment and the importance of a multidisciplinary approach.
1.50